Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1

Cancer Research

Volumn 61, Issue 24, 2001, Pages 8866-8872

  Hunter, Kent W ^a   Lukes, Luanne ^a   Cozma, Diana ^a   Rouse, Jessica ^a   Broman, Karl W ^b   Le Voyer, Thomas ^c   Debies, Michael T ^d   Welch, Danny R ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d PENN STATE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BRMS1 GENE; CANCER MODEL; CHROMOSOME 13; CHROMOSOME 17; CHROMOSOME 19; CHROMOSOME 6; CHROMOSOME 9; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE LOCATION; GENE MAPPING; GENETIC VARIABILITY; INBRED STRAIN; METASTASIS; MOUSE; MTES1 GENE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ANIMALS; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; INBREEDING; LUNG NEOPLASMS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED DBA; MICE, TRANSGENIC; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROTEINS;

EID: 0035893391     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Principles of molecular cell biology of cancer: Cancer metastasis
2. Preclinical models for the evaluation of targeted therapies of metastatic disease
3. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell
4. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype
5. Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancer
6. Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis
7. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis
8. Stromal-epithelial interaction in type IV collagenase expression and activation: The role in cancer metastasis
9. Autocrine motility factor and the extracellular matrix. II. Degradation or remodeling of substratum components directs the motile response of tumor cells
10. Autocrine motility factor and the extracellular matrix. I. Coordinate regulation of melanoma cell adhesion, spreading and migration involves focal contact reorganization
11. Genetic and epigenetic regulation of human breast cancer progression and metastasis
12. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13
13. Evidence for a novel gene associated with low tumor metastatic potential
14. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene
15. KAII, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma
16. E-cadherin expression: A counterbalance for cancer cell invasion
17. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17
18. Stromelysin in tumor progression and metastasis
19. Maspin suppresses the invasive phenotype of human breast carcinoma
20. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression
21. An epistatic interaction controls the latency of a transgene-induced mammary tumor
22. Three loci modify growth of a transgene-induced mammary tumor: Suppression of proliferation associated with decreased microvessel density
23. Prognostic factors in breast carcinoma with negative axillary lymph nodes
24. Prognostic indicators in early breast cancer
25. Prognostic factors in primary breast cancer
26. Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis
27. Relation of tumor size, lymph node status, and survival in 24, 740 breast cancer cases
28. Development and use of a natural history data base of breast cancer studies
29. Survival and prognostic factors in node-negative breast cancer: Results of long-term follow-up studies
30. Long term analysis of factors influencing the outcome in carcinoma of the breast smaller than one centimeter
31. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma
32. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease
33. Mapping mendelian factors underlying quantitative traits using RFLP linkage maps
34. A nonparametric approach for mapping quantitative trait loci
35. Multigenic control of Listeria monocytogenes susceptibility in mice
36. Empirical threshold values for quantitative trait mapping
37. Type I and type II error rates for quantitative trait loci (QTL) mapping studies using recombinant inbred mouse strains
38. Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse
39. High frequency of interactions between lung cancer susceptibility genes in the mouse: Mapping of Sluc5 to Sluc14
40. Genetics of quantitative and qualitative aspects of lung tumorigenesis in the mouse: Multiple interacting Susceptibility to lung cancer (Sluc) genes with large effects
41. The Mouse Genome Database (MGD): Integration nexus for the laboratory mouse
42. Basic local alignment search tool
43. Cross-referencing radiation hybrid data to the recombination map: Lessons from mouse chromosome 18
44. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression
45. Overexpression of c-Met protein in human thyroid tumors correlated with lymph node metastasis and clinicopathologic stage
46. Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis
47. Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells
48. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication